8-K
Current Report
Prelude Therapeutics Inc Filed Acc 0001564590-22-023674
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading prld-8k_20220617.htm…